Richard C. Yocum serves as Executive at HALOZYME THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Richard C. Yocum has executed 10 insider transactions totaling $253.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 22, 2007 involved selling 100 shares valued at $849.
Richard C. Yocum currently holds 86,975 shares of HALOZYME THERAPEUTICS INC (HTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard C. Yocum has been a net seller of HTI stock. They have purchased $0 and sold $253.5K worth of shares.
Richard C. Yocum's most recent insider trade was on Mar 22, 2007, when they sold 100 shares at $8.49 per share.
Get notified when new Form 4 filings are submitted
| $8.46 |
| Discretionary |
| Mar 22, 2007 | HTI | $70.1K | Sale | 8,300 | $8.45 | Discretionary |
| Mar 22, 2007 | HTI | $1.3K | Sale | 158 | $8.47 | Discretionary |
| Mar 22, 2007 | HTI | $152.2K | Sale | 17,900 | $8.50 | Discretionary |
| Mar 22, 2007 | HTI | $22.2K | Sale | 2,600 | $8.52 | Discretionary |
| Mar 22, 2007 | HTI | $2.6K | Sale | 300 | $8.56 | Discretionary |
| Mar 22, 2007 | HTI | $1.7K | Sale | 200 | $8.63 | Discretionary |
| Mar 21, 2007 | HTI | $123.4K | Option Exercise | 65,975 | $1.87 | Discretionary |
| Mar 21, 2007 | HTI | $55.8K | Option Exercise | 29,858 | $1.87 | Discretionary |